Medicare 2027 Negotiating Class: Austedo, Linzess, Xifaxan May Face Generic, OTC Price Comparators

30 Jan 2025

• By Cathy Kelly

Manufacturers will address what constitutes appropriate therapeutic alternatives for the selected drugs as part of the negotiation process.

Will generic or OTC alternatives lower the bar for Medicare negotiated prices? (Shutterstock)

More from Medicare

More from Geography